Tilray’s Good Supply Cannabis Brand Launches ‘Peppermint Phatty’ 510 Vape

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), launched Peppermint Phatty 510 vape, the newest addition to the Good Supply vape lineup.

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY), launched Peppermint Phatty 510 vape, the newest addition to the Good Supply vape lineup.

Just in time for the holidays, Peppermint Phatty is packed with peppermint and vanilla aromas and topped off with a slight cooling sensation. These 1g 510 cartridges deliver the company’s most potent vape yet.

“With the launch of Peppermint Phatty, our most refreshing tasting vape yet, customers can expect the same features like high quality cartridges and innovative flavor formulations that have made Good Supply so recognizable and respected among Canadian cannabis enthusiasts,” stated Michelle Morin, brand manager.

Good Supply’s Peppermint Phatty vape is now available across Canada.

About Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through quality, differentiated brands and products. Tilray’s production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Tim Foster on Unsplash

Related News

Marijuana Banking Reform On Hold As House Lawmakers Disagree On Defense Bill Inclusion Option

Tilray Stock Flies High Amid SAFE Banking Hopes: Here’s Why Sentiment Has Turned Bullish

MMJ Dispensaries In Alabama, Cannabis In Ohio & Poland, Texas Decrim Debate, MI’s Weed Testing Labs

 

Total
0
Shares
Related Posts
Read More

VBI Vaccines Inc. Announces The Borrowers And The Lenders Have Agreed To Extend The Forbearance Period Until January 23, 2024, If Conditions Not Met, The Period Will Be Terminated And K2 HealthVentures LLC May Declare An Event Of Default

 As previously disclosed, on November 13, 2023, VBI Vaccines Inc. (the "Company") along with its subsidiary VBI Cda (collectively, the "Borrowers") entered into a forbearance agreement (the "Forbearance Agreement")

VBIV